HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice. It is an owner and operator of inpatient rehabilitation hospitals. It provides specialized rehabilitative treatment on both an inpatient and outpatient basis. It offers its home health and hospice services through Encompass Home Health and Hospice business (Encompass). Encompass operates home health and hospice agencies in 25 states, with concentrations in the Southeast, Oklahoma, and Texas. As of December 31, 2016, the Company operated 123 inpatient rehabilitation hospitals. As of December 31, 2016, the Company managed five inpatient rehabilitation units through management contracts.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Healthcare Facilities & Services - NEC
- Sub-Industry: Health Care Facilities
- Symbol: NYSE:HLS
- CUSIP: 42192430
- Web: www.healthsouth.com
- Market Cap: $4.09917 billion
- Outstanding Shares: 89,521,000
- 50 Day Moving Avg: $47.08
- 200 Day Moving Avg: $43.94
- 52 Week Range: $36.97 - $49.71
Sales & Book Value:
- Trailing P/E Ratio: 17.18
- Foreward P/E Ratio: 15.97
- P/E Growth: 1.72
- Annual Revenue: $3.71 billion
- Price / Sales: 1.11
- Book Value: $8.71 per share
- Price / Book: 5.28
- Annual Dividend: $0.96
- Dividend Yield: 2.1%
- EBIDTA: $824.9 million
- Net Margins: 6.80%
- Return on Equity: 28.73%
- Return on Assets: 5.66%
- Debt-to-Equity Ratio: 2.98%
- Current Ratio: 1.40%
- Quick Ratio: 1.40%
- Average Volume: 981,960 shs.
- Beta: 0.63
- Short Ratio: 6.9
Frequently Asked Questions for HealthSouth Corporation (NYSE:HLS)
What is HealthSouth Corporation's stock symbol?
HealthSouth Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "HLS."
How often does HealthSouth Corporation pay dividends? What is the dividend yield for HealthSouth Corporation?
HealthSouth Corporation announced a quarterly dividend on Friday, May 5th. Stockholders of record on Monday, July 3rd will be paid a dividend of $0.24 per share on Monday, July 17th. This represents a $0.96 annualized dividend and a dividend yield of 2.09%. The ex-dividend date of this dividend is Thursday, June 29th. View HealthSouth Corporation's Dividend History.
How were HealthSouth Corporation's earnings last quarter?
HealthSouth Corporation (NYSE:HLS) released its quarterly earnings results on Thursday, April, 27th. The company reported $0.70 EPS for the quarter, topping the Zacks' consensus estimate of $0.65 by $0.05. The business had revenue of $974.80 million for the quarter, compared to analyst estimates of $960.05 million. HealthSouth Corporation had a net margin of 6.80% and a return on equity of 28.73%. HealthSouth Corporation's quarterly revenue was up 7.1% on a year-over-year basis. During the same period in the previous year, the business earned $0.61 earnings per share. View HealthSouth Corporation's Earnings History.
What guidance has HealthSouth Corporation issued on next quarter's earnings?
HealthSouth Corporation issued an update on its FY17 earnings guidance on Thursday, April, 27th. The company provided earnings per share (EPS) guidance of $2.61-2.73 for the period, compared to the Thomson Reuters consensus estimate of $2.67. The company issued revenue guidance of $3.85-3.95 billion, compared to the consensus revenue estimate of $3.92 billion.
Where is HealthSouth Corporation's stock going? Where will HealthSouth Corporation's stock price be in 2017?
9 brokerages have issued 1 year price objectives for HealthSouth Corporation's stock. Their predictions range from $45.00 to $54.00. On average, they anticipate HealthSouth Corporation's share price to reach $48.83 in the next year. View Analyst Ratings for HealthSouth Corporation.
Who are some of HealthSouth Corporation's key competitors?
Some companies that are related to HealthSouth Corporation include Mednax (MD), NMC Health PLC (NMC), Acadia Healthcare Company (ACHC), Molina Healthcare (MOH), Chemed Corp. (CHE), LifePoint Health (LPNT), Select Medical Holdings Corporation (SEM), Udg Healthcare PLC (UDG), Tenet Healthcare Corporation (THC), HMS Holdings Corp (HMSY), Community Health Systems (CYH), Kindred Healthcare (KND), HealthStream (HSTM), China Cord Blood Corporation (CO), American Renal Associates Holdings (ARA), Georgia Healthcare Group PLC (GHG), Cambian Group PLC (CMBN) and Concord Medical Services Holdings Limited (CCM).
Who are HealthSouth Corporation's key executives?
HealthSouth Corporation's management team includes the folowing people:
- Mark J. Tarr, President, Chief Executive Officer
- Douglas E. Coltharp, Chief Financial Officer, Executive Vice President
- April Anthony, Chief Executive Officer and President - Encompass
- Cheryl B. Levy, Chief Human Resource Officer
- Patrick Darby, Executive Vice President, General Counsel, Secretary
- Barbara A. Jacobsmeyer, Executive Vice President - Operations
- Edmund M. Fay, Senior Vice President, Treasurer
- Andrew L. Price CPA, Chief Accounting Officer
- Elissa Joy Charbonneau, Chief Medical Officer
- Leo I. Higdon Jr., Non-Executive Independent Chairman of the Board
Who owns HealthSouth Corporation stock?
HealthSouth Corporation's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Mackay Shields LLC (0.91%), Reinhart Partners Inc. (0.57%), Bank of Montreal Can (0.27%), Capstone Asset Management Co. (0.16%), Sit Investment Associates Inc. (0.06%) and Prescott Group Capital Management L.L.C. (0.06%). Company insiders that own HealthSouth Corporation stock include Cheryl B Levy, Douglas E Coltharp, Edmund Fay, Joan E Herman, John Chidsey, Leo I Higdon Jr and Mark J Tarr. View Institutional Ownership Trends for HealthSouth Corporation.
Who sold HealthSouth Corporation stock? Who is selling HealthSouth Corporation stock?
HealthSouth Corporation's stock was sold by a variety of institutional investors in the last quarter, including Reinhart Partners Inc., Bank of Montreal Can, Creative Planning, US Bancorp DE, Sit Investment Associates Inc. and Fox Run Management L.L.C.. View Insider Buying and Selling for HealthSouth Corporation.
Who bought HealthSouth Corporation stock? Who is buying HealthSouth Corporation stock?
HealthSouth Corporation's stock was acquired by a variety of institutional investors in the last quarter, including Mackay Shields LLC, Legato Capital Management LLC, Visionary Asset Management Inc., OLD National Bancorp IN, Capstone Asset Management Co., Aperio Group LLC, Oregon Public Employees Retirement Fund and LS Investment Advisors LLC. Company insiders that have bought HealthSouth Corporation stock in the last two years include Douglas E Coltharp, Joan E Herman, John Chidsey, Leo I Higdon Jr and Mark J Tarr. View Insider Buying and Selling for HealthSouth Corporation.
How do I buy HealthSouth Corporation stock?
Shares of HealthSouth Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is HealthSouth Corporation's stock price today?
MarketBeat Community Rating for HealthSouth Corporation (NYSE HLS)MarketBeat's community ratings are surveys of what our community members think about HealthSouth Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of HealthSouth Corporation stock can currently be purchased for approximately $46.00.
Consensus Ratings for HealthSouth Corporation (NYSE:HLS) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||1 Sell Rating, 2 Hold Ratings, 6 Buy Ratings|
|Consensus Rating:||Buy (Score: 2.56)|
|Consensus Price Target: ||$48.83 (6.16% upside)|
Analysts' Ratings History for HealthSouth Corporation (NYSE:HLS)
(Data available from 7/21/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|7/10/2017||Mizuho||Boost Price Target||Neutral -> Neutral||$44.00 -> $47.00||Medium|
|7/5/2017||Royal Bank Of Canada||Reiterated Rating||Buy||$53.00||High|
|6/15/2017||KeyCorp||Initiated Coverage||Sector Weight -> Sector Weight||Low|
|5/1/2017||Barclays PLC||Reiterated Rating||Underweight||$44.00 -> $46.00||Low|
|2/22/2017||Stephens||Upgrade||Equal Weight -> Overweight||N/A|
|2/13/2017||Craig Hallum||Initiated Coverage||Buy||$48.00||N/A|
|1/3/2017||Piper Jaffray Companies||Initiated Coverage||Neutral||$45.00||N/A|
|9/11/2016||Wells Fargo & Company||Reiterated Rating||Buy||N/A|
|9/4/2016||JMP Securities||Reiterated Rating||Buy||N/A|
|8/1/2016||SunTrust Banks, Inc.||Set Price Target||Buy||$54.00||N/A|
|5/16/2016||Robert W. Baird||Reiterated Rating||Buy||N/A|
|2/25/2016||Susquehanna Bancshares Inc||Lower Price Target||Positive||$50.00 -> $42.00||N/A|
|11/6/2015||Wedbush||Lower Price Target||Neutral||$51.00 -> $45.00||N/A|
|10/30/2015||Raymond James Financial, Inc.||Reiterated Rating||Outperform||$51.00 -> $42.00||N/A|
|10/29/2015||Stifel Nicolaus||Downgrade||Buy -> Hold||$52.00||N/A|
Earnings History for HealthSouth Corporation (NYSE:HLS)Earnings History by Quarter for HealthSouth Corporation (NYSE HLS)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|4/27/2017||Q1 2017||$0.65||$0.70||$960.05 million||$974.80 million||View||N/A|
|2/21/2017||Q416||$0.62||$0.72||$951.18 million||$949.90 million||View||N/A|
|10/27/2016||Q316||$0.60||$0.65||$448.60 million||$926.80 million||View||N/A|
|7/28/2016||Q2||$0.60||$0.69||$906.67 million||$920.70 million||View||N/A|
|4/26/2016||Q116||$0.55||$0.61||$892.87 million||$909.80 million||View||N/A|
|2/23/2016||Q415||$0.59||$0.59||$859.48 million||$879.30 million||View||Listen|
|10/28/2015||Q315||$0.59||$0.52||$756.85 million||$778.60 million||View||Listen|
|7/29/2015||Q215||$0.58||$0.47||$746.86 million||$764.40 million||View||Listen|
|4/30/2015||Q115||$0.56||$0.44||$731.30 million||$740.60 million||View||N/A|
|2/24/2015||Q414||$0.52||$0.55||$609.40 million||$613.40 million||View||N/A|
|10/27/2014||Q314||$0.48||$0.53||$595.30 million||$597.00 million||View||N/A|
|7/28/2014||Q214||$0.47||$0.54||$588.94 million||$604.40 million||View||N/A|
|4/28/2014||Q114||$0.49||$0.48||$594.07 million||$591.20 million||View||N/A|
|2/19/2014||Q413||$0.43||$0.52||$575.55 million||$572.10 million||View||N/A|
|10/29/2013||Q313||$0.41||$0.59||$557.50 million||$564.00 million||View||N/A|
|7/25/2013||Q2 2013||$0.42||$0.51||$553.63 million||$564.50 million||View||N/A|
|4/25/2013||Q1 2013||$0.42||$0.48||$563.86 million||$572.60 million||View||N/A|
Earnings Estimates for HealthSouth Corporation (NYSE:HLS)
2017 EPS Consensus Estimate: $2.67
2018 EPS Consensus Estimate: $2.84
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Current Dividend Information for HealthSouth Corporation (NYSE:HLS)
|Most Recent Dividend:||7/17/2017|
|Dividend Growth:||72.90% (3 Year Average)|
|Payout Ratio:||35.96% (Trailing 12 Months of Earnings) |
35.42% (Based on This Year's Estimates)
33.33% (Based on Next Year's Estimates)
|Track Record:||3 Years of Consecutive Dividend Growth|
Dividend History by Quarter for HealthSouth Corporation (NYSE HLS)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading and Institutional Ownership History for HealthSouth Corporation (NYSE:HLS)
Insider Ownership Percentage: 1.60%Insider Trades by Quarter for HealthSouth Corporation (NYSE:HLS)
Institutional Ownership Percentage: 96.98%
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|11/9/2016||Douglas E Coltharp||CFO||Buy||6,450||$39.14||$252,453.00|| |
|11/9/2016||Mark J Tarr||COO||Buy||6,371||$39.29||$250,316.59|| |
|8/2/2016||Mark J Tarr||COO||Sell||20,000||$41.85||$837,000.00|| |
|4/29/2016||Cheryl B Levy||Insider||Sell||11,000||$41.44||$455,840.00|| |
|3/1/2016||Edmund Fay||Treasurer||Sell||16,240||$35.50||$576,520.00|| |
|1/11/2016||John Chidsey||Director||Buy||799||$35.78||$28,588.22|| |
|11/5/2015||Joan E Herman||Director||Buy||1,000||$35.28||$35,280.00|| |
|11/2/2015||Leo I Higdon Jr||Director||Buy||1,000||$34.81||$34,810.00|| |
|2/27/2015||Andrew L Price||CAO||Sell||1,145||$43.84||$50,196.80|| |
|2/27/2015||Mark J Tarr||COO||Sell||11,000||$43.82||$482,020.00|| |
|5/9/2014||Jay Grinney||CEO||Sell||38,000||$33.42||$1,269,960.00|| |
|5/6/2014||Jay Grinney||CEO||Sell||50,000||$34.51||$1,725,500.00|| |
|3/7/2014||Jay Grinney||CEO||Sell||89,000||$32.57||$2,898,730.00|| |
|11/14/2013||Mark Tarr||COO||Sell||11,000||$35.27||$387,970.00|| |
|5/6/2013||Leslye G Katz||Director||Buy||1,000||$28.40||$28,400.00|| |
|11/7/2012||Jay Grinney||CEO||Buy||11,300||$21.95||$248,035.00|| |
Headline Trends for HealthSouth Corporation (NYSE:HLS)
Latest Headlines for HealthSouth Corporation (NYSE:HLS)
HealthSouth Corporation (HLS) Chart for Friday, July, 21, 2017